SPY302.97-0.56 -0.18%
DIA254.35-1.42 -0.56%
IXIC9,368.99-43.37 -0.46%

Aprea Therapeutics Q1 EPS $(0.450) Up From $(2.970) YoY

Aprea Therapeutics (NASDAQ:APRE) reported quarterly losses of $(0.450) per share. This is a 84.85 percent increase over losses of $(2.970) per share from the same period last year.

Benzinga · 05/15/2020 11:35

Aprea Therapeutics (NASDAQ:APRE) reported quarterly losses of $(0.450) per share. This is a 84.85 percent increase over losses of $(2.970) per share from the same period last year.